Clinical Trials List
2022-04-15 - 2027-04-30
Phase I/II
Recruiting3
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Trial Applicant
A2 HEALTHCARE TAIWAN CORPORATION
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Tzu-Yao Liao Division of Hematology & Oncology
- Chia-Hsun Lu Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林哲銘 Division of Radiology
- YING-CHI TSENG Division of Radiology
- 呂曉薇 Division of Otolaryngology
- 陳美茜 Division of Otolaryngology
- TSU-YI CHAO Division of Hematology & Oncology
- 林以志 Division of Otolaryngology
- Tsung-Ming Chen Division of Otolaryngology
- HUI-WEN LIU Division of Hematology & Oncology
- 王興萬 Division of Otolaryngology
- 莊博雅 Division of Hematology & Oncology
- Pin-Zhir Chao Division of Otolaryngology
- Yao-Yu Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yu-Min Liao Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
55 participants
